Capricor Therapeutics Inc (CAPR)

Capricor Therapeutics Inc (CAPR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $384M; returns 1 day -3.3%, 1 week -11.6%, 1 year -3.3%.

Capricor Therapeutics, Inc. (CAPR) is a clinical-stage biotechnology company focused on developing cell and exosome-based therapeutics for muscular and other rare diseases.

Groups CAPR belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Rare Diseases
• Duchenne Muscular Dystrophy
• Biopharmaceutical
• Regenerative Medicine
• Life Sciences
• Clinical Stage

CAPR financial model: income statement, cash flow and balance sheet